PENTAX Medical Launches Innovative J10 Series Endoscopic Ultrasound Gastroscopes In the USA

September 15, 2020

PENTAX Medical has announced the launch of the new J10 Series Ultrasound Video Gastroscopes.

In assessing GI diseases, endoscopic ultrasound (EUS) is a minimally invasive and highly accurate procedure that uses high-frequency sound waves to produce detailed images of tissue and surrounding organs such as the pancreas and liver. While used primarily for diagnostic procedures such as EUS-guided Fine Needle Aspiration (EUS-FNA), EUS-guided Fine Needle Biopsy (EUS-FNB), and tumor staging, there has been a shift towards using EUS for interventional procedures and to treat pancreaticobiliary diseases as a less-invasive option than ERCP.

The new PENTAX Medical J10 Series Ultrasound Video Gastroscopes deliver on both clinical and market needs, offering ergonomic design, renowned image quality and enhanced maneuverability as an EUS solution.

With ultrasound gastroscopes, high functionality and performance are critical for success, given that indications are so varied. Designed for optimal procedural efficiency in EUS, the new J10 Series Ultrasound Video Gastroscopes provide a lightweight and ergonomic control body design to ensure stability and ease of intubation while reducing hand fatigue. With a proven PENTAX-Hitachi image quality to support visual certainty and diagnoses, the J10 Series produces greater detail, clearer delineation, and superior penetration. Additionally, maneuvering, device control, and instrument compatibility are augmented with shorter rigid distal section lengths, increased tip deflection, smaller bending radius and an enlarged working channel.

“With the immense success of the J10 Series endoscopes since their introduction in other global regions, we are now very pleased and excited for their introduction in the USA as well,” stated Gerald W. Bottero, Global President of PENTAX Medical. “With a focus on exceptional maneuverability and high-definition endoscopic imaging, the J10 Series provides an innovative solution for performing endoscopic evaluations, increasing diagnostic capabilities, and determining pathways for effective patient management.”

Specific enhancements with the new J10 Series Ultrasound Video Gastroscopes include increased linear scope scan angle of 150° for broader imaging, increased frequency (13MHz) for near-field exploration, widened depth of field range (3mm–100mm), increased angulations to optimize access in the GI tract, and sealed elevator wire channels to help reduce risk of cross-contamination. The EG38-J10UT also has an enlarged instrument channel width (4mm), expanding therapeutic capabilities to advance EUS-guided intervention while providing full control of the procedure.

The new J10 Series is really a step forward in the set-up and portfolio of endoscopic ultrasound,” said Dr. Paolo G. Arcidiacono, Ospedale San Raffaele, Milan, Italy. “It is a significant improvement on both the endoscopic and the endosonographic side. Particularly for therapeutic procedures, the improved endoscopic view has solved previous compromises.”

The J10 Series is commercially available now. An exclusive Virtual Launch Event is scheduled for October 14, 2020 at 6:00 PM EDT. Three renowned endoscopic ultrasound experts will present difficult EUS cases and discuss the potential benefits and differences of the new J10 Series lineup.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”